Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "RAMOSE Trial - Osimertinib+/-Ramucirumab in TKI-Naïve EGFRm mNSCLC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Xiuning Le
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Xiuning Le
229 views
November 8, 2023
Comments 0
Login to view comments.
Click here to Login
Lung